256 related articles for article (PubMed ID: 6684481)
1. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
[TBL] [Abstract][Full Text] [Related]
2. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
3. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
Cassels R; Fears R; Smith RA
Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
Fischer B
Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
[TBL] [Abstract][Full Text] [Related]
5. Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.
Yonekawa O; Voskuilen M; Nieuwenhuizen W
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):187-91. PubMed ID: 1567367
[TBL] [Abstract][Full Text] [Related]
6. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW
Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143
[TBL] [Abstract][Full Text] [Related]
7. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments.
Nieuwenhuizen W; Keyser J
Thromb Res; 1985 Jun; 38(6):663-70. PubMed ID: 4040660
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2.
Nieuwenhuizen W; Verheijen JH; Vermond A; Chang GT
Biochim Biophys Acta; 1983 Feb; 755(3):531-3. PubMed ID: 6681716
[TBL] [Abstract][Full Text] [Related]
9. Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activator.
Verheijen JH; Nieuwenhuizen W; Traas DW; Chang GT; Hoegee E
Thromb Res; 1983 Oct; 32(1):87-92. PubMed ID: 6229056
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
Zamarron C; Lijnen HR; Collen D
J Biol Chem; 1984 Feb; 259(4):2080-3. PubMed ID: 6538196
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation.
Beckmann R; Geiger M; Binder BR
J Biol Chem; 1988 May; 263(15):7176-80. PubMed ID: 2966802
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
14. Location of plasminogen-binding sites in human fibrin(ogen).
VĂ¡radi A; Patthy L
Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
[TBL] [Abstract][Full Text] [Related]
16. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Matsuo O; Collen D
Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
Lee PP; Wohl RC; Boreisha IG; Robbins KC
Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
[TBL] [Abstract][Full Text] [Related]
19. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.
Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH
J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505
[TBL] [Abstract][Full Text] [Related]
20. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
de Serrano VS; Urano T; Gaffney PJ; Castellino FJ
J Protein Chem; 1989 Feb; 8(1):61-77. PubMed ID: 2527513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]